Standout Papers
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer (2017)
- Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial (2019)
Immediate Impact
13 by Nobel laureates 8 from Science/Nature 67 standout
Citing Papers
Prostate Cancer
2025 Standout
Renal cell carcinoma
2024 Standout
Works of Andrew Protheroe being referenced
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
2019 Standout
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Andrew Protheroe | 3171 | 1333 | 927 | 1763 | 1349 | 122 | 5.8k | |
| Hao Wang | 2405 | 1898 | 683 | 1259 | 992 | 124 | 4.6k | |
| Venkatraman Seshan | 2330 | 2662 | 619 | 2892 | 1618 | 122 | 7.7k | |
| Ingela Turesson | 5372 | 2507 | 929 | 1894 | 2005 | 118 | 9.2k | |
| Kevin M. Slawin | 6736 | 1822 | 1470 | 1959 | 1277 | 180 | 9.7k | |
| John Staffurth | 2721 | 1058 | 735 | 829 | 860 | 115 | 4.2k | |
| Albert J.H. Suurmeijer | 2640 | 2097 | 1901 | 1515 | 587 | 206 | 8.0k | |
| Vivian Weinberg | 3291 | 2153 | 2076 | 885 | 753 | 172 | 7.6k | |
| Geert J.L.H. van Leenders | 5827 | 1199 | 1548 | 1672 | 1120 | 184 | 8.2k | |
| Michael K. Brawer | 6821 | 1082 | 1322 | 1510 | 1080 | 168 | 8.8k | |
| Christina Messiou | 2378 | 2049 | 559 | 974 | 489 | 174 | 5.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...